Literature DB >> 6726903

Contemporary cystectomy with pelvic node dissection compared to preoperative radiation therapy plus cystectomy in management of invasive bladder cancer.

D G Skinner, G Lieskovsky.   

Abstract

Between August 1971 and August 1982, 197 consecutive patients underwent single stage radical cystectomy with pelvic lymph node dissection and urinary diversion as definitive management of high grade, invasive bladder cancer. In 100 patients 1,600 rad of radiation therapy were given for 4 days preoperatively and 97 patients underwent an operation only. Although not constituting a prospective randomized study, an analysis of these 2 groups of patients managed during an 11-year period by the same surgical team, using identical surgical technique, provides useful information that questions the benefit of preoperative radiation therapy in the management of high grade, invasive bladder cancer. Other factors, such as improved surgical technique with meticulous pelvic node dissection as well as better preoperative and postoperative care, may be responsible for survival results of contemporary surgery only that equal those reported following combination therapy protocols using preoperative radiation therapy. Contemporary surgery with or without preoperative radiation therapy yielded a 5-year survival rate free of tumor of 75 per cent for patients with pathologic stages P2 and P3A disease, 44 per cent with P3A and P3B disease, and 36 per cent with P4 disease and positive pelvic nodes.

Entities:  

Mesh:

Year:  1984        PMID: 6726903     DOI: 10.1016/s0022-5347(17)50809-5

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  25 in total

Review 1.  Complications associated with urinary diversion.

Authors:  Richard E Hautmann; Stefan H Hautmann; Oliver Hautmann
Journal:  Nat Rev Urol       Date:  2011-11-01       Impact factor: 14.432

Review 2.  The emerging role of antibody-drug conjugates in urothelial carcinoma.

Authors:  Michael Lattanzi; Jonathan E Rosenberg
Journal:  Expert Rev Anticancer Ther       Date:  2020-07-21       Impact factor: 4.512

Review 3.  Tumors of the kidney, ureter, and bladder.

Authors:  W A See; R D Williams
Journal:  West J Med       Date:  1992-05

Review 4.  Bladder cancer.

Authors:  H Y Leung; T R Griffiths; D E Neal
Journal:  Postgrad Med J       Date:  1996-12       Impact factor: 2.401

Review 5.  Epidermal growth factor receptor and bladder cancer.

Authors:  A J Colquhoun; J K Mellon
Journal:  Postgrad Med J       Date:  2002-10       Impact factor: 2.401

6.  Surveillance strategies after definitive therapy of invasive bladder cancer.

Authors:  Ilias Cagiannos; Christopher Morash
Journal:  Can Urol Assoc J       Date:  2009-12       Impact factor: 1.862

7.  Incidence of urethral tumor involvement in 910 men with bladder cancer.

Authors:  M Erckert; A Stenzl; M Falk; G Bartsch
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

8.  Orthotopic urinary diversion: the Kock ileal neobladder.

Authors:  D A Elmajian; J P Stein; D G Skinner
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

Review 9.  Contemporary management of muscle-invasive bladder cancer.

Authors:  Marc A Dall'Era; Liang Cheng; Chong-Xian Pan
Journal:  Expert Rev Anticancer Ther       Date:  2012-07       Impact factor: 4.512

10.  The value of tumour spread, grading and growth pattern as morphological predictive parameters in bladder carcinoma. A critical revision of the 1987 TNM classification.

Authors:  J C Angulo; J I Lopez; N Flores; J D Toledo
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.